It is an important point but we cant at the moment say anything about that, he said. The first thing we can say based on these data, is that when you are offered the second dose, please also take that because its very important. That rose to more than 85% after the second dose. The study was not set up to look at any differences between the two. He said the numbers were consistent with a relatively constant protection of about 70% at that stage.
You will die from the flu vaccine.
( z0 die :ARG1 ( z1 you ) :ARG1-of ( z2 cause :ARG0 ( z3 vaccine :purpose ( z4 disease :name ( z5 name :op "influenza" ) ) ) ) )
(z0 / die-01
    :ARG1 (z1 / you)
    :ARG1-of (z2 / cause-01
                 :ARG0 (z3 / vaccine
                           :purpose (z4 / disease
                                        :name (z5 / name
                                                  :op1 "influenza")))))
You will die from the flu vaccine .
z0 :ARG1 z1
z0 :ARG1-of z2
z4 :name z5
z5 :op1 0
z3 :purpose z4
z2 :ARG0 z3